Paradigm Biopharmaceuticals Limited (PAR.AX) - Stock Prices, Stock Peers & Analysis

Home
PAR.AX

Company Name	Paradigm Biopharmaceuticals Limited
Symbol	PAR.AX
Currency	AUD
Price	0.225
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	78,766,200
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.165 - 0.48
Industry	Biotechnology
Sector	Healthcare
CEO	Mr. Paul John Rennie BSc, Grad Dip, MBM, MSTC
Website	https://www.paradigmbiopharma.com

An error occurred while fetching data.

About Paradigm Biopharmaceuticals Limited

Paradigm Biopharmaceuticals Limited, a drug repurposing company, engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, and acute respiratory distress syndrome diseases. The company